Universe · entity
Vivo Capital, LLC
Institutional manager (13F) · CIK 1674712
13F holdings · as of 2026-03-31 · top 45 · reported portfolio $1.2B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | Erasca Inc | $197M | 12,151,480 |
| 2 | Praxis Precision Medicines | $109M | 338,895 |
| 3 | Terns Pharmaceuticals Inc | $70M | 1,334,418 |
| 4 | Trevi Therapeutics Inc | $61M | 5,094,668 |
| 5 | DBV Technologies SA | $56M | 2,667,569 |
| 6 | Compass Therapeutics Inc | $50M | 9,545,466 |
| 7 | Tango Therapeutics Inc | $45M | 2,154,780 |
| 8 | SAB Biotherapeutics Inc | $44M | 11,420,000 |
| 9 | Corvus Pharmaceuticals Holdings | $41M | 2,805,816 |
| 10 | Bright Minds Biosciences Inc | $41M | 557,172 |
| 11 | Sinovac Biotech Ltd. | $38M | 5,903,000 |
| 12 | Dianthus Therapeutics Inc | $30M | 353,998 |
| 13 | Dyne Therapeutics Inc | $28M | 1,557,466 |
| 14 | Abivax SA - ADR | $27M | 239,539 |
| 15 | Minerva Neurosciences Inc | $26M | 4,322,747 |
| 16 | Aclaris Therapeutics, Inc. | $25M | 6,666,666 |
| 17 | Oric Pharmaceuticals Inc | $23M | 1,848,786 |
| 18 | Alto Neuroscience Inc | $23M | 1,035,551 |
| 19 | Sensei Biotherapeutics Inc | $23M | 722,020 |
| 20 | Arrivent BioPharma Inc | $20M | 885,916 |
| 21 | LB Pharmaceuticals Inc | $20M | 800,000 |
| 22 | Veradermics Inc | $19M | 300,000 |
| 23 | CAMP4 Therapeutics Inc | $19M | 4,246,568 |
| 24 | Moonlake Immunotherapeutics | $19M | 1,000,000 |
| 25 | Design Therapeutics Inc | $17M | 1,612,903 |
| 26 | Cogent Biosciences Inc | $16M | 422,300 |
| 27 | Geron Corp | $13M | 8,671,797 |
| 28 | Unicycive Therapeutics | $12M | 1,789,916 |
| 29 | AN2 Therapeutics Inc | $11M | 3,153,640 |
| 30 | Olema Pharmaceuticals Inc | $10M | 671,843 |
| 31 | Soleno Therapeutics Inc | $10M | 294,909 |
| 32 | Eupraxia Pharmaceuticals Inc | $10M | 1,350,000 |
| 33 | Onkure Therapeutics Inc | $8M | 1,927,710 |
| 34 | Surrozen Inc | $8M | 260,000 |
| 35 | ALX Oncology Holdings Inc | $6M | 3,184,713 |
| 36 | Monopar Therapeutics Inc | $5M | 90,500 |
| 37 | Pepgen Inc | $4M | 2,325,000 |
| 38 | Sera Prognostics Inc | $3M | 1,650,440 |
| 39 | Tenax Therapeutics Inc | $3M | 208,333 |
| 40 | Viridian Therapeutics Inc | $3M | 166,288 |
| 41 | Instil Bio Inc | $2M | 292,743 |
| 42 | Pasithea Therapeutics Corp | $2M | 2,100,000 |
| 43 | Compass Pathway PLC | $1M | 200,000 |
| 44 | Bolt Therapeutics Inc | $293k | 72,414 |
| 45 | Precision Biosciences Inc | $26k | 4,675 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.